Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01335581Not ApplicableCompleted

Study of Laser Treatment of Melasma

Role: lead

NCT01452490Not ApplicableCompleted

Diode Laser Treatment of Onychomycosis

Role: lead

NCT01221922Not ApplicableCompleted

Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI

Role: lead

NCT00955461Not ApplicableCompleted

Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System

Role: lead

All 4 trials loaded